May 2012
ASLME Insider: Your Health Law Home
ASLME Home JOIN NOW Forward Issue to a Friend Manage Your eNewsletter Subscription Search Back Issues
In This Issue
35th Health Law Professors Conference
19th World Congress on Medical Law
Society Scoop
Conferences and Events
Getting Into Funded Research: An Introduction to Winning Grants for Professors
Join us for the 2012 Public Health Law Conference
JLME Update
Where in the World is JLME?
Member Spotlight: Sharona Hoffman
Connect With Us
facebook twitter linkedin
JLME Update

JLME is celebrating its 40th anniversary! We hope you enjoyed the spring cover that kicked off our celebratory spirit. In case you’ve missed it, the cover showed several editions of past JLMEs—from its humble beginnings as a newsletter to the multi-page journal you read today. Our first issue of the year, “The Graying of America: Challenges and Controversies,” guest by Robert M. Sade, is now available online. Please click here to read the latest articles.

Now we are working on the summer issue, “Pharmaceutical Firms and the Right to Health,” guest edited by Thana Campos and Thomas Pogge. This symposium is a result of a two-day conference in 2010 at the University of Sao Paulo (Brazil) and its Centre for the Study of Violence (NEV/USP). The distinguished cohort of authors examine global health inequities and pharmaceutical policy matters. The right to health remains a much discussed topic, and the authors employ several perspectives in discussing the role that government and pharmaceutical companies play in providing access to medicines. Brazil, for example, has become a leader in global health because of both its domestic policy and international influence. Stating in their Constitution that “health is a right of all and a duty of the State,” the Brazilian government is also leading efforts for global collaborations with the United Nations and World Trade Organization. The authors also discuss pharmaceutical patents and the availability of generic medicines, the new international organization called the Health Impact Fund, and pharmaceutical companies’ responsibilities to protect health and human rights—among many other topics. The issues are not new, but the authors provide innovative solutions that reflect the changing scope of global health and pharmaceutical policy.

Thank you for reading JLME and celebrating its anniversary all year with us! If you would like to share your thoughts on an article or have a suggestion for us, please feel free to contact us. As always, we value your continued readership of JLME. We look forward to hearing from you.

To ensure delivery of ASLME Insider, please add to your email address book or Safe Sender List.If you are still having problems receiving our communications, see our white-listing page for more details.

American Society of Law, Medicine & Ethics
765 Commonwealth Avenue, Suite 1634
Boston, MA 02215